INR 121.7
(2.4%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 7.08 Million INR | -99.54% |
2022 | 1.54 Billion INR | 690277.68% |
2021 | 224 Thousand INR | -84.17% |
2020 | 1.41 Million INR | -97.63% |
2019 | 59.6 Million INR | -96.21% |
2018 | 1.57 Billion INR | 12.64% |
2017 | 1.39 Billion INR | 50.76% |
2016 | 925.11 Million INR | 10.84% |
2015 | 834.64 Million INR | 2.03% |
2014 | 818.05 Million INR | 4.04% |
2013 | 786.28 Million INR | 46.11% |
2012 | 538.14 Million INR | 15.73% |
2011 | 465.01 Million INR | 39.37% |
2010 | 333.65 Million INR | 9.43% |
2009 | 304.9 Million INR | 12.08% |
2008 | 272.04 Million INR | 11.49% |
2007 | 244.01 Million INR | 6.56% |
2006 | 228.99 Million INR | 0.71% |
2005 | 227.38 Million INR | 17.75% |
2004 | 193.11 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 7.04 Million INR | 0.0% |
2024 Q1 | - INR | -100.0% |
2023 FY | 7.08 Million INR | -99.54% |
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 7.08 Million INR | 0.0% |
2023 Q2 | 7.36 Million INR | 0.0% |
2022 Q2 | 224 Thousand INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 1.54 Billion INR | 690277.68% |
2022 Q4 | 1.54 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 Q2 | 1.5 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 224 Thousand INR | -84.17% |
2021 Q4 | 224 Thousand INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 1.41 Million INR | -97.63% |
2020 Q2 | 1.5 Million INR | 0.0% |
2020 Q4 | 1.41 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 FY | 59.6 Million INR | -96.21% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 1.52 Billion INR | 0.0% |
2019 Q4 | 2.89 Million INR | 0.0% |
2018 FY | 1.57 Billion INR | 12.64% |
2018 Q1 | - INR | 0.0% |
2018 Q4 | 1.57 Billion INR | 0.0% |
2017 FY | 1.39 Billion INR | 50.76% |
2016 FY | 925.11 Million INR | 10.84% |
2016 Q4 | 925.11 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 FY | 834.64 Million INR | 2.03% |
2015 Q4 | 834.64 Million INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 1.03 Billion INR | 0.0% |
2014 Q4 | 818.05 Million INR | 0.0% |
2014 Q2 | 610.04 Million INR | 0.0% |
2014 FY | 818.05 Million INR | 4.04% |
2014 Q1 | - INR | -100.0% |
2014 Q3 | - INR | -100.0% |
2013 FY | 786.28 Million INR | 46.11% |
2013 Q4 | 786.28 Million INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 671.5 Million INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2012 Q2 | 853.88 Million INR | 0.0% |
2012 Q4 | 538.14 Million INR | 0.0% |
2012 FY | 538.14 Million INR | 15.73% |
2011 FY | 465.01 Million INR | 39.37% |
2010 FY | 333.65 Million INR | 9.43% |
2009 FY | 304.9 Million INR | 12.08% |
2008 FY | 272.04 Million INR | 11.49% |
2007 FY | 244.01 Million INR | 6.56% |
2006 FY | 228.99 Million INR | 0.71% |
2005 FY | 227.38 Million INR | 17.75% |
2004 FY | 193.11 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.957% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.993% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 99.894% |
Granules India Limited | 13 Billion INR | 99.946% |
Indoco Remedies Limited | 3.53 Billion INR | 99.799% |
Achyut Healthcare Limited | 568 Thousand INR | -1147.359% |
Ajanta Pharma Limited | 8.28 Billion INR | 99.914% |
Alkem Laboratories Limited | 26.61 Billion INR | 99.973% |
Alpa Laboratories Limited | 136.65 Million INR | 94.815% |
Brooks Laboratories Limited | 96.1 Million INR | 92.628% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 99.689% |
Bajaj HealthCare Limited | 1.44 Billion INR | 99.508% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 99.402% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.989% |
Eris Lifesciences Limited | 1.89 Billion INR | 99.625% |
FDC Limited | 3.88 Billion INR | 99.818% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.972% |
Gufic Biosciences Limited | 2 Billion INR | 99.647% |
Ind-Swift Laboratories Limited | 104.57 Million INR | 93.225% |
Ipca Laboratories Limited | 24.71 Billion INR | 99.971% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 95.276% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | 92.768% |
Lasa Supergenerics Limited | 190.43 Million INR | 96.28% |
Laurus Labs Limited | 18.45 Billion INR | 99.962% |
Lupin Limited | 49.53 Billion INR | 99.986% |
Mankind Pharma Limited | 15.53 Billion INR | 99.954% |
Medicamen Biotech Limited | 593.75 Million INR | 98.807% |
Medico Remedies Limited | 163.37 Million INR | 95.663% |
Megasoft Limited | - INR | -Infinity% |
NATCO Pharma Limited | 7 Billion INR | 99.899% |
Piramal Pharma Limited | 21.75 Billion INR | 99.967% |
RPG Life Sciences Limited | 1.01 Billion INR | 99.299% |
Sigachi Industries Limited | 707.2 Million INR | 98.998% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.993% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 99.694% |
Syncom Formulations (India) Limited | 210.81 Million INR | 96.639% |
Unichem Laboratories Limited | 7.04 Billion INR | 99.899% |
Wanbury Limited | 360.23 Million INR | 98.033% |
Windlas Biotech Limited | 621.89 Million INR | 98.861% |
ZIM Laboratories Limited | 812.62 Million INR | 99.128% |
Zydus Lifesciences Limited | 34.41 Billion INR | 99.979% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Divi's Laboratories Limited | 31.84 Billion INR | 99.978% |
Hester Biosciences Limited | 755.81 Million INR | 99.063% |
Procter & Gamble Health Limited | 1.09 Billion INR | 99.351% |
Amrutanjan Health Care Limited | 289.04 Million INR | 97.549% |
Bal Pharma Limited | 878.11 Million INR | 99.193% |
Strides Pharma Science Limited | 11.26 Billion INR | 99.937% |
Venus Remedies Limited | 1.21 Billion INR | 99.418% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 99.89% |
Nectar Lifesciences Limited | 7.09 Billion INR | 99.9% |
Shilpa Medicare Limited | 3.44 Billion INR | 99.795% |
Aarti Drugs Limited | 4.85 Billion INR | 99.854% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 99.833% |
Ind-Swift Limited | 640.91 Million INR | 98.895% |
Valiant Laboratories Limited | 100.15 Million INR | 92.926% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 99.859% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 99.803% |
Themis Medicare Limited | 705.74 Million INR | 98.996% |
Hikal Limited | 3.03 Billion INR | 99.767% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.969% |
Sequent Scientific Limited | 3.46 Billion INR | 99.795% |
Novartis India Limited | 448.6 Million INR | 98.421% |
Wockhardt Limited | 6.4 Billion INR | 99.889% |
Jubilant Pharmova Limited | 12.89 Billion INR | 99.945% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | 72.212% |
Neuland Laboratories Limited | 3.5 Billion INR | 99.798% |
Morepen Laboratories Limited | 2.48 Billion INR | 99.715% |
Kilitch Drugs (India) Limited | 39.88 Million INR | 82.234% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 99.427% |